Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesEffect of Duration and Intermittency of Rifampin on Tuberculosis Treatment Outcomes: A Systematic Review and Meta-Analysis
PLoS Medicine, 09/18/09
Menzies D et al. – This review provides evidence against continued use of regimens that utilize rifampin for the first 2 mo only, as they are significantly and substantially inferior to regimens that use rifampin for at least 6 mo. This review also has identified an important need for adequately powered clinical trials that address dosing schedules, management of isoniazid mono–resistance, and the optimal duration of treatment to prevent relapse.
Related Articles
Rapid detection of Mycobacterium tuberculosis and rifampin-resistance using on-demand, near patient technology
Journal of Clinical Microbiology, 10/30/09
Relevance Score: 66%
Smoking and Risk of Tuberculosis Incidence, Mortality, and Recurrence in South Korean Men and Women
American Journal of Epidemiology, 11/18/09
Relevance Score: 46%
Implications of the global financial crisis for the response to diseases of poverty within overall health sector development: the case of tuberculosis
Tropical Medicine & International Health, 11/10/09
Relevance Score: 45%
Immunopathogenesis and Diagnosis of Tuberculosis and Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome during Early Antiretroviral Therapy
The Journal of Infectious Diseases, 11/03/09
Relevance Score: 45%
Follow-up results of 702 patients receiving tumor necrosis factor-alpha antagonists and evaluation of risk of tuberculosis
Rheumatology International, 10/29/09
Relevance Score: 45%
Today in Antimicrobials...keeping you current
Receive free subspecialty "5-minute updates" via email
Infections after the use of alemtuzumab in solid organ transplant recipients: a comparative study
Diagnostic Microbiology and Infectious Disease, 12/09/09
Screening of some Tanzanian medicinal plants for their trypanocidal and cytotoxic activities
Phytotherapy Research, 12/09/09
Routine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): a randomised non-inferiority trial
The Lancet - Early Online Publication, 12/09/09
Sponsor
Article Search
Sponsor